ECPC has recently published the Polish version of the Biosimilars E-modules toolkit which has been developed in collaboration with ecancer to provide patients with a comprehensive resource on biosimilar medicines. Six interactive modules provide key information and practical advice to support you in making informed decisions for your treatment
ECPC strongly believes that patients must be informed in order to take an active role in the decision-making concerning their treatment and we have developed this tool to allow patients to do so. A biosimilar is a highly similar copy of an off-patent biological medicine which is already available on the market under a different trademark. Biosimilars have the potential to increase access to medicines by improving the financial sustainability of our healthcare systems.
If you represent one of ECPC’s member organisations, we encourage you to share this e-learning tool with your colleagues.